tradingkey.logo
tradingkey.logo
Search

Regentis Biomaterials Ord Shs

RGNT
Add to Watchlist
1.750USD
-0.050-2.78%
Close 07-31 16:00ETQuotes delayed by 15 min
0.00Market Cap
--P/E TTM

Regentis Biomaterials Ord Shs

1.750
-0.050-2.78%

Shareholding Stats

Updated: Thu, May 7
Updated: Thu, May 7
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
HaisThera Scientific Fund I, L.P
11.90%
Vitalife Life Sciences Venture Capital
7.74%
Ocorian Fund Management S.a.r.l
5.72%
Medica Venture Partners
5.05%
DSM Venturing B.V.
5.04%
Other
64.54%
Shareholders
Shareholders
Proportion
HaisThera Scientific Fund I, L.P
11.90%
Vitalife Life Sciences Venture Capital
7.74%
Ocorian Fund Management S.a.r.l
5.72%
Medica Venture Partners
5.05%
DSM Venturing B.V.
5.04%
Other
64.54%
Shareholder Types
Shareholders
Proportion
Corporation
17.63%
Venture Capital
12.78%
Private Equity
9.28%
Hedge Fund
5.06%
Individual Investor
1.42%
Other
53.84%

Institutional Shareholding

Updated: Wed, Apr 1
Updated: Wed, Apr 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2026Q1
8
1.40M
27.12%
+611.09K

Shareholder Activity

Name
Shares Held
Proportion
Change
Chg %
Date
HaisThera Scientific Fund I, L.P
616.61K
11.9%
+616.61K
--
Feb 20, 2026
Vitalife Life Sciences Venture Capital
400.94K
7.74%
+400.94K
--
Feb 20, 2026
Ocorian Fund Management S.a.r.l
296.37K
5.72%
+296.37K
--
Feb 20, 2026
Medica Venture Partners
261.78K
5.05%
-512.73K
-66.20%
Feb 20, 2026
DSM Venturing B.V.
261.02K
5.04%
+261.02K
--
Feb 20, 2026
Rosalind Advisors, Inc.
251.51K
4.86%
+251.51K
--
Dec 31, 2025
Ben-Elazar (Pini)
73.54K
1.42%
+73.54K
--
Feb 20, 2026
Citadel Advisors LLC
10.41K
0.2%
+10.41K
--
Dec 31, 2025
View more
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.